Clinical Trials Directory

Trials / Completed

CompletedNCT05526872

A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer Screening

Patient Reminders and Self-Referrals Via Online Patient Portals and Text Messaging (PReVenT) to Improve Adherence to Breast Cancer Screening

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
140 (actual)
Sponsor
Emory University · Academic / Other
Sex
Female
Age
50 Years – 74 Years
Healthy volunteers
Accepted

Summary

This clinical trial evaluates the patient reminders and self-referrals via online patient portals and text messaging (PReVenT) intervention for improving adherence to breast cancer screening. Though no doctor referral is required for mammography, adherence to screening mammograms remains low. Barriers to screening mammography can include things like forgetfulness, low motivation, high cost, or lack of knowledge. Patient reminders and self-scheduling assistance may overcome some of these barriers by increasing patients' awareness, motivating them to schedule their mammogram, and improving access by removing the need for a healthcare provider to order the exam. The PReVenT intervention uses online and text-message based patient-reminders and self-referral assistance to increase adherence to breast cancer screening.

Detailed description

PRIMARY OBJECTIVES; I. Compare the screening mammogram (SM) completion rates between PReVenT and enhanced usual care (EUC) arms at 6 months. II. Describe patient's experience with the PReVenT intervention using mixed methods stratified by completion of SM. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants receive usual care as well as a portal message reminder to schedule a SM and a callback link if they need assistance. Participants who have not or do not schedule their SM at the time of the first reminder receive a reminder text-message one week later with a link to receive assistance with scheduling. ARM II: Participants receive usual care as well as portal and text messages one week apart with educational materials about healthy eating. After completion of study, patients are followed up at 6 months.

Conditions

Interventions

TypeNameDescription
OTHERBest PracticeReceive usual care
BEHAVIORALHealth EducationReceive educational materials
OTHERInterviewAncillary studies
OTHERPlanned NotificationReceive planned reminders to schedule mammogram
OTHERSurvey AdministrationAncillary studies

Timeline

Start date
2022-09-05
Primary completion
2024-03-31
Completion
2024-06-01
First posted
2022-09-02
Last updated
2024-06-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05526872. Inclusion in this directory is not an endorsement.